Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "The Primary Endpoint Analysis of the Phase II SCARLET Study - Sotorasib + Carboplatin-Pemetrexed in Pts With Advanced Non-Squamous NSCLC With KRAS G12C Mutation"

250 views
June 15, 2023
Comments 0
Login to view comments. Click here to Login